As government and industry leaders look to rein in the cost of healthcare, The Hill and Express Scripts will convene a forward-looking conversation on biosimilar drugs and how they could affect healthcare access and affordability.
Featuring
DAN DURHAM, Executive Vice President for Policy & Regulatory Affairs, AHIP Dr. STEVEN MILLER, Senior Vice President & Chief Medical Officer, Express Scripts LORI REILLY, Executive Vice President for Policy & Research, PhRMA MATT SALO, Executive Director, National Association of Medicaid Directors
Register here.